Immuno-oncology Diagnosis Market, Global Outlook and Forecast 2023-2030
This report aims to provide a comprehensive presentation of the global market for Immuno-oncology Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-oncology Diagnosis. This report contains market size and forecasts of Immuno-oncology Diagnosis in global, including the following market information:
Global Immuno-oncology Diagnosis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Immuno-oncology Diagnosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immuno-oncology Diagnosis include 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-oncology Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-oncology Diagnosis Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, by Type, 2022 (%)
PCR
NGS
Immunoassay
Global Immuno-oncology Diagnosis Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, by Application, 2022 (%)
Research
Diagnostics
Global Immuno-oncology Diagnosis Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-oncology Diagnosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immuno-oncology Diagnosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioM?rieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Protagen Diagnostics
Qiagen
Quanterix
Rarecells SAS
Roche Diagnostics
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-oncology Diagnosis, market overview.
Chapter 2: Global Immuno-oncology Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Immuno-oncology Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-oncology Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
